Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays.
Identifieur interne : 001103 ( Main/Exploration ); précédent : 001102; suivant : 001104Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays.
Auteurs : Baptiste Demey [France] ; Nagib Daher ; Catherine François [France] ; Jean-Philippe Lanoix ; Gilles Duverlie [France] ; Sandrine Castelain [France] ; Etienne Brochot [France]Source :
- The Journal of infection [ 1532-2742 ] ; 2020.
Descripteurs français
- KwdFr :
- Anticorps antiviraux (analyse), Anticorps antiviraux (immunologie), Betacoronavirus (immunologie), Dosage immunologique (méthodes), Humains (MeSH), Infections à coronavirus (diagnostic), Infections à coronavirus (ethnologie), Infections à coronavirus (immunologie), Pandémies (MeSH), Pneumopathie virale (diagnostic), Pneumopathie virale (immunologie), Réaction de polymérisation en chaine en temps réel (MeSH), Sensibilité et spécificité (MeSH), Techniques de laboratoire clinique (méthodes).
- MESH :
- analyse : Anticorps antiviraux.
- diagnostic : Infections à coronavirus, Pneumopathie virale.
- ethnologie : Infections à coronavirus.
- immunologie : Anticorps antiviraux, Betacoronavirus, Infections à coronavirus, Pneumopathie virale.
- méthodes : Dosage immunologique, Techniques de laboratoire clinique.
- Humains, Pandémies, Réaction de polymérisation en chaine en temps réel, Sensibilité et spécificité.
English descriptors
- KwdEn :
- Antibodies, Viral (analysis), Antibodies, Viral (immunology), Betacoronavirus (immunology), Clinical Laboratory Techniques (methods), Coronavirus Infections (diagnosis), Coronavirus Infections (ethnology), Coronavirus Infections (immunology), Humans (MeSH), Immunoassay (methods), Pandemics (MeSH), Pneumonia, Viral (diagnosis), Pneumonia, Viral (immunology), Real-Time Polymerase Chain Reaction (MeSH), Sensitivity and Specificity (MeSH).
- MESH :
- chemical , analysis : Antibodies, Viral.
- chemical , immunology : Antibodies, Viral.
- diagnosis : Coronavirus Infections, Pneumonia, Viral.
- ethnology : Coronavirus Infections.
- immunology : Betacoronavirus, Coronavirus Infections, Pneumonia, Viral.
- methods : Clinical Laboratory Techniques, Immunoassay.
- Humans, Pandemics, Real-Time Polymerase Chain Reaction, Sensitivity and Specificity.
Abstract
In order to fight the SARS-CoV-2 pandemic infection, there is a growing need and demand for diagnostic tools that are complementary and different from the RT-PCR currently in use. Multiple serological tests are or will be very soon available but need to be evaluated and validated. We have thus tested 4 immunochromatographic tests for the detection of antibodies to SARS-CoV-2. In addition, we assessed the kinetics of antibody appearance using these assays in 22 patients after they were tested positive by RT-PCR. We observed great heterogeneity in antibody detection post-symptom onset. The median antibody detection time was between 8 and 10 days according to the manufacturers. All the tests showed a sensitivity of 60 to 80% on day 10 and 100% on day 15. In addition, a single cross-reaction was observed with other human coronavirus infections. Thus, immunochromatographic tests for the detection of anti-SARS-CoV-2 antibodies may have their place for the diagnostic panel of COVID-19.
DOI: 10.1016/j.jinf.2020.04.033
PubMed: 32389784
PubMed Central: PMC7204722
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays.</title><author><name sortKey="Demey, Baptiste" sort="Demey, Baptiste" uniqKey="Demey B" first="Baptiste" last="Demey">Baptiste Demey</name><affiliation wicri:level="3"><nlm:affiliation>Department of Virology, Amiens University Medical Center, Amiens, France; AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Virology, Amiens University Medical Center, Amiens, France; AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens</wicri:regionArea><placeName><region type="region">Hauts-de-France</region><region type="old region">Picardie</region><settlement type="city">Amiens</settlement></placeName></affiliation></author><author><name sortKey="Daher, Nagib" sort="Daher, Nagib" uniqKey="Daher N" first="Nagib" last="Daher">Nagib Daher</name><affiliation><nlm:affiliation>Department of Gynecology-Obstetrics, University Hospital, Amiens.</nlm:affiliation><wicri:noCountry code="subField">Amiens</wicri:noCountry></affiliation></author><author><name sortKey="Francois, Catherine" sort="Francois, Catherine" uniqKey="Francois C" first="Catherine" last="François">Catherine François</name><affiliation wicri:level="3"><nlm:affiliation>Department of Virology, Amiens University Medical Center, Amiens, France; AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Virology, Amiens University Medical Center, Amiens, France; AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens</wicri:regionArea><placeName><region type="region">Hauts-de-France</region><region type="old region">Picardie</region><settlement type="city">Amiens</settlement></placeName></affiliation></author><author><name sortKey="Lanoix, Jean Philippe" sort="Lanoix, Jean Philippe" uniqKey="Lanoix J" first="Jean-Philippe" last="Lanoix">Jean-Philippe Lanoix</name><affiliation><nlm:affiliation>AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens, France; Infectious Diseases Department, University Hospital, Amiens.</nlm:affiliation><wicri:noCountry code="subField">Amiens</wicri:noCountry></affiliation></author><author><name sortKey="Duverlie, Gilles" sort="Duverlie, Gilles" uniqKey="Duverlie G" first="Gilles" last="Duverlie">Gilles Duverlie</name><affiliation wicri:level="3"><nlm:affiliation>Department of Virology, Amiens University Medical Center, Amiens, France; AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Virology, Amiens University Medical Center, Amiens, France; AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens</wicri:regionArea><placeName><region type="region">Hauts-de-France</region><region type="old region">Picardie</region><settlement type="city">Amiens</settlement></placeName></affiliation></author><author><name sortKey="Castelain, Sandrine" sort="Castelain, Sandrine" uniqKey="Castelain S" first="Sandrine" last="Castelain">Sandrine Castelain</name><affiliation wicri:level="3"><nlm:affiliation>Department of Virology, Amiens University Medical Center, Amiens, France; AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Virology, Amiens University Medical Center, Amiens, France; AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens</wicri:regionArea><placeName><region type="region">Hauts-de-France</region><region type="old region">Picardie</region><settlement type="city">Amiens</settlement></placeName></affiliation></author><author><name sortKey="Brochot, Etienne" sort="Brochot, Etienne" uniqKey="Brochot E" first="Etienne" last="Brochot">Etienne Brochot</name><affiliation wicri:level="3"><nlm:affiliation>Department of Virology, Amiens University Medical Center, Amiens, France; AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens, France. Electronic address: etienne.brochot@u-picardie.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Virology, Amiens University Medical Center, Amiens, France; AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens</wicri:regionArea><placeName><region type="region">Hauts-de-France</region><region type="old region">Picardie</region><settlement type="city">Amiens</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32389784</idno><idno type="pmid">32389784</idno><idno type="doi">10.1016/j.jinf.2020.04.033</idno><idno type="pmc">PMC7204722</idno><idno type="wicri:Area/Main/Corpus">001363</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001363</idno><idno type="wicri:Area/Main/Curation">001363</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001363</idno><idno type="wicri:Area/Main/Exploration">001363</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays.</title><author><name sortKey="Demey, Baptiste" sort="Demey, Baptiste" uniqKey="Demey B" first="Baptiste" last="Demey">Baptiste Demey</name><affiliation wicri:level="3"><nlm:affiliation>Department of Virology, Amiens University Medical Center, Amiens, France; AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Virology, Amiens University Medical Center, Amiens, France; AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens</wicri:regionArea><placeName><region type="region">Hauts-de-France</region><region type="old region">Picardie</region><settlement type="city">Amiens</settlement></placeName></affiliation></author><author><name sortKey="Daher, Nagib" sort="Daher, Nagib" uniqKey="Daher N" first="Nagib" last="Daher">Nagib Daher</name><affiliation><nlm:affiliation>Department of Gynecology-Obstetrics, University Hospital, Amiens.</nlm:affiliation><wicri:noCountry code="subField">Amiens</wicri:noCountry></affiliation></author><author><name sortKey="Francois, Catherine" sort="Francois, Catherine" uniqKey="Francois C" first="Catherine" last="François">Catherine François</name><affiliation wicri:level="3"><nlm:affiliation>Department of Virology, Amiens University Medical Center, Amiens, France; AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Virology, Amiens University Medical Center, Amiens, France; AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens</wicri:regionArea><placeName><region type="region">Hauts-de-France</region><region type="old region">Picardie</region><settlement type="city">Amiens</settlement></placeName></affiliation></author><author><name sortKey="Lanoix, Jean Philippe" sort="Lanoix, Jean Philippe" uniqKey="Lanoix J" first="Jean-Philippe" last="Lanoix">Jean-Philippe Lanoix</name><affiliation><nlm:affiliation>AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens, France; Infectious Diseases Department, University Hospital, Amiens.</nlm:affiliation><wicri:noCountry code="subField">Amiens</wicri:noCountry></affiliation></author><author><name sortKey="Duverlie, Gilles" sort="Duverlie, Gilles" uniqKey="Duverlie G" first="Gilles" last="Duverlie">Gilles Duverlie</name><affiliation wicri:level="3"><nlm:affiliation>Department of Virology, Amiens University Medical Center, Amiens, France; AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Virology, Amiens University Medical Center, Amiens, France; AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens</wicri:regionArea><placeName><region type="region">Hauts-de-France</region><region type="old region">Picardie</region><settlement type="city">Amiens</settlement></placeName></affiliation></author><author><name sortKey="Castelain, Sandrine" sort="Castelain, Sandrine" uniqKey="Castelain S" first="Sandrine" last="Castelain">Sandrine Castelain</name><affiliation wicri:level="3"><nlm:affiliation>Department of Virology, Amiens University Medical Center, Amiens, France; AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Virology, Amiens University Medical Center, Amiens, France; AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens</wicri:regionArea><placeName><region type="region">Hauts-de-France</region><region type="old region">Picardie</region><settlement type="city">Amiens</settlement></placeName></affiliation></author><author><name sortKey="Brochot, Etienne" sort="Brochot, Etienne" uniqKey="Brochot E" first="Etienne" last="Brochot">Etienne Brochot</name><affiliation wicri:level="3"><nlm:affiliation>Department of Virology, Amiens University Medical Center, Amiens, France; AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens, France. Electronic address: etienne.brochot@u-picardie.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Virology, Amiens University Medical Center, Amiens, France; AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens</wicri:regionArea><placeName><region type="region">Hauts-de-France</region><region type="old region">Picardie</region><settlement type="city">Amiens</settlement></placeName></affiliation></author></analytic><series><title level="j">The Journal of infection</title><idno type="eISSN">1532-2742</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibodies, Viral (analysis)</term><term>Antibodies, Viral (immunology)</term><term>Betacoronavirus (immunology)</term><term>Clinical Laboratory Techniques (methods)</term><term>Coronavirus Infections (diagnosis)</term><term>Coronavirus Infections (ethnology)</term><term>Coronavirus Infections (immunology)</term><term>Humans (MeSH)</term><term>Immunoassay (methods)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (diagnosis)</term><term>Pneumonia, Viral (immunology)</term><term>Real-Time Polymerase Chain Reaction (MeSH)</term><term>Sensitivity and Specificity (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Anticorps antiviraux (analyse)</term><term>Anticorps antiviraux (immunologie)</term><term>Betacoronavirus (immunologie)</term><term>Dosage immunologique (méthodes)</term><term>Humains (MeSH)</term><term>Infections à coronavirus (diagnostic)</term><term>Infections à coronavirus (ethnologie)</term><term>Infections à coronavirus (immunologie)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (diagnostic)</term><term>Pneumopathie virale (immunologie)</term><term>Réaction de polymérisation en chaine en temps réel (MeSH)</term><term>Sensibilité et spécificité (MeSH)</term><term>Techniques de laboratoire clinique (méthodes)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Antibodies, Viral</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Viral</term></keywords><keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>Anticorps antiviraux</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="ethnologie" xml:lang="fr"><term>Infections à coronavirus</term></keywords><keywords scheme="MESH" qualifier="ethnology" xml:lang="en"><term>Coronavirus Infections</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Anticorps antiviraux</term><term>Betacoronavirus</term><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Betacoronavirus</term><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Clinical Laboratory Techniques</term><term>Immunoassay</term></keywords><keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Dosage immunologique</term><term>Techniques de laboratoire clinique</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Pandemics</term><term>Real-Time Polymerase Chain Reaction</term><term>Sensitivity and Specificity</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Pandémies</term><term>Réaction de polymérisation en chaine en temps réel</term><term>Sensibilité et spécificité</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In order to fight the SARS-CoV-2 pandemic infection, there is a growing need and demand for diagnostic tools that are complementary and different from the RT-PCR currently in use. Multiple serological tests are or will be very soon available but need to be evaluated and validated. We have thus tested 4 immunochromatographic tests for the detection of antibodies to SARS-CoV-2. In addition, we assessed the kinetics of antibody appearance using these assays in 22 patients after they were tested positive by RT-PCR. We observed great heterogeneity in antibody detection post-symptom onset. The median antibody detection time was between 8 and 10 days according to the manufacturers. All the tests showed a sensitivity of 60 to 80% on day 10 and 100% on day 15. In addition, a single cross-reaction was observed with other human coronavirus infections. Thus, immunochromatographic tests for the detection of anti-SARS-CoV-2 antibodies may have their place for the diagnostic panel of COVID-19.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32389784</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>06</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2742</ISSN><JournalIssue CitedMedium="Internet"><Volume>81</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>08</Month></PubDate></JournalIssue><Title>The Journal of infection</Title><ISOAbbreviation>J. Infect.</ISOAbbreviation></Journal><ArticleTitle>Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays.</ArticleTitle><Pagination><MedlinePgn>e6-e10</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0163-4453(20)30244-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jinf.2020.04.033</ELocationID><Abstract><AbstractText>In order to fight the SARS-CoV-2 pandemic infection, there is a growing need and demand for diagnostic tools that are complementary and different from the RT-PCR currently in use. Multiple serological tests are or will be very soon available but need to be evaluated and validated. We have thus tested 4 immunochromatographic tests for the detection of antibodies to SARS-CoV-2. In addition, we assessed the kinetics of antibody appearance using these assays in 22 patients after they were tested positive by RT-PCR. We observed great heterogeneity in antibody detection post-symptom onset. The median antibody detection time was between 8 and 10 days according to the manufacturers. All the tests showed a sensitivity of 60 to 80% on day 10 and 100% on day 15. In addition, a single cross-reaction was observed with other human coronavirus infections. Thus, immunochromatographic tests for the detection of anti-SARS-CoV-2 antibodies may have their place for the diagnostic panel of COVID-19.</AbstractText><CopyrightInformation>Copyright © 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Demey</LastName><ForeName>Baptiste</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Virology, Amiens University Medical Center, Amiens, France; AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daher</LastName><ForeName>Nagib</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Gynecology-Obstetrics, University Hospital, Amiens.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>François</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Virology, Amiens University Medical Center, Amiens, France; AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanoix</LastName><ForeName>Jean-Philippe</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens, France; Infectious Diseases Department, University Hospital, Amiens.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duverlie</LastName><ForeName>Gilles</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Virology, Amiens University Medical Center, Amiens, France; AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castelain</LastName><ForeName>Sandrine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Virology, Amiens University Medical Center, Amiens, France; AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brochot</LastName><ForeName>Etienne</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Virology, Amiens University Medical Center, Amiens, France; AGIR Research Unit, EA4294, Jules Verne University of Picardie, Amiens, France. Electronic address: etienne.brochot@u-picardie.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Infect</MedlineTA><NlmUniqueID>7908424</NlmUniqueID><ISSNLinking>0163-4453</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Protocol" UI="C000657964">COVID-19 diagnostic testing</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Infect. 2020 Sep;81(3):452-482</RefSource><PMID Version="1">32540458</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019411" MajorTopicYN="N">Clinical Laboratory Techniques</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007118" MajorTopicYN="N">Immunoassay</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Antibody</Keyword><Keyword MajorTopicYN="Y">COVID-19</Keyword><Keyword MajorTopicYN="Y">Lateral flow assay</Keyword><Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest All authors have no conflict of interest to declare</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>04</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32389784</ArticleId><ArticleId IdType="pii">S0163-4453(20)30244-9</ArticleId><ArticleId IdType="doi">10.1016/j.jinf.2020.04.033</ArticleId><ArticleId IdType="pmc">PMC7204722</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Hauts-de-France</li><li>Picardie</li></region><settlement><li>Amiens</li></settlement></list><tree><noCountry><name sortKey="Daher, Nagib" sort="Daher, Nagib" uniqKey="Daher N" first="Nagib" last="Daher">Nagib Daher</name><name sortKey="Lanoix, Jean Philippe" sort="Lanoix, Jean Philippe" uniqKey="Lanoix J" first="Jean-Philippe" last="Lanoix">Jean-Philippe Lanoix</name></noCountry><country name="France"><region name="Hauts-de-France"><name sortKey="Demey, Baptiste" sort="Demey, Baptiste" uniqKey="Demey B" first="Baptiste" last="Demey">Baptiste Demey</name></region><name sortKey="Brochot, Etienne" sort="Brochot, Etienne" uniqKey="Brochot E" first="Etienne" last="Brochot">Etienne Brochot</name><name sortKey="Castelain, Sandrine" sort="Castelain, Sandrine" uniqKey="Castelain S" first="Sandrine" last="Castelain">Sandrine Castelain</name><name sortKey="Duverlie, Gilles" sort="Duverlie, Gilles" uniqKey="Duverlie G" first="Gilles" last="Duverlie">Gilles Duverlie</name><name sortKey="Francois, Catherine" sort="Francois, Catherine" uniqKey="Francois C" first="Catherine" last="François">Catherine François</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001103 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001103 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32389784
|texte= Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32389784" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |